Following the latest publication by The Lancet's of preliminary Phase-3 trial results from the Russian COVID vaccine showing a 91,6 percent efficacy, RT speaks to David Livermore, Professor of Medical Microbiology at the University of East Anglia, about a variety of issues such as western skepticism towards the Russian jab, the question of politicizing the medicine, and co-operation between countries in the fight against COVID.